CGA-IGC 2025 Visit Us At Booth #6

CGA-IGC annual meeting


Ambry Genetics is a proud sponsor and exhibitor of CGA-IGC 2025.  Check out our posters and Symposium presentation to learn more about Ambry's latest research!

We're Excited For You to Join Us

Meet the Experts

Friday, October 10 2:50pm

Booth #6 315 Chestnut St, St. Louis, MO 63102 US

Meet Ambry Scientific Experts at CGA-IGC! We'll be at booth 6. Stop by or register using the link below.

  • Tina Pesaran, MA, MS, CGC - Friday 10/10 2:50-3:10PM (coffee break) - As Vice President of Genomic Science at Ambry Genetics, Tina oversees a multidisciplinary team driving advancements in variant and gene assessment, medical informatics, and computational biology. Come chat with Tina about her commitment to evidence-based classification frameworks and Ambry’s mission to improve interpretation accuracy.
  • Holly LaDuca, MS, CGC - Friday 10/10 2:50-3:10PM (coffee break) - In her role as a Clinical Strategy Manger, Holly works cross functionally with the Marketing, R&D, and Medical teams at Ambry to develop strategies that meet patient and provider needs in the hereditary cancer space. In particular, Holly is passionate about using translational and implementation science as a means to advance patient care. Meet Holly at the booth to learn more.
  • Jennifer Herrera-Mullar, MS, CGC, DMA - Friday 10/10 2:50-3:10PM (coffee break) - Jeni is a Principal Clinical Scientist and a member of the Gene Team at Ambry. In this role, she evaluates gene-disease relationships of newly described and well-established genes with a focus on how evidence scoring must be adapted for common diseases like cancer. Come by the booth to learn from Jeni about pleiotropy, phenopy, and penetrance – oh my!
RSVP

Please Join Us for a Symposium

GI Classifi-ed: Our Comprehensive and Adaptive Approach to Genomic Results Interpretation​

Friday, October 10 7:00am

Hyatt Regency St. Louis at The Arch 315 Chestnut St, St. Louis, 315 Chestnut St, St. Louis, MO 63102 US

Classifi integrates multispecialty scientific expertise with technology to scale the delivery of high-quality genetic test results. The session will demonstrate how the integration of these components impacts test accuracy now and in the future, with a focus on hereditary gastrointestinal cancer conditions.​


Presented by:​
Holly LaDuca, MS, CGC, Clinical Strategy Manager, Ambry Genetics​

Jeni Herrera-Mullar, MGC, LCGC, DMA,  Principal Clinical Scientist, Ambry Genetics​

Tina Pesaran, MA, MS, CGC, Vice President, Genomic Science, Ambry Genetics

Research

Contact an Author

Scientific Posters

Poster # tbd

Thursday, October 9, 2025 8:00 - 8:00pm

Marcy E. Richardson, Taylor D. Coleman, Carrie Horton, Magan Trottier, Linda Polfus​, Leah Zaretsky, Aimee Lucas. An update on APC p.I1307K homozygosity: Observations from 74 individuals from a large multigene panel testing cohort.

Poster # tbd

Thursday, October 9, 2025 8:00 - 8:00pm

Kevin Beezhold, Cassidy Carraway, Jennifer Herrera Mullar. Cancer Prevalence in MSH3 Heterozygotes.

Oral Presentations

Session # tbd

Thursday, October 9, 2025 1:30 - 3:00pm

Jennifer Herrera-Mullar, Cassidy Carraway, Ashley PL Marsh, Zahra Heidari, Rachel Jones, Felicia Hernandez, Emily Kudalkar, Marcy E. Richardson. Analysis of missense variants in RPS20 and an association with colorectal cancer predisposition

Session # tbd

Saturday, October 11, 2025 1:30 - 3:00pm

Katherine L. Belshe, Jordyn Koehn, Alisdair Philp, Bryson Katona, Stephen Hyter, Rashna Madan, Barry Skikne, Abdulraheem Yacoub, Andrew K. Godwin, Marcy E. Richardson, Cassidy Carraway, Jeffrey N. Weitzel, Ajay Bansal. Beyond familial adenomatous polyposis: using genotype-phenotype correlations to discern germline versus somatic status for APC whole gene deletions among 860,000 tests

Get in Touch With Us While You are Here

Set up a Meeting

Our Blog

Read our blog on why Ambry is using evidence-based quality testing.

Read More

Search Results

Start your search...